CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net loss	$ (18,866,300)	$ (10,267,100)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	64,800	65,300
Stock-based compensation	2,519,700	1,386,900
Expense related to modification of warrants	25,800	292,700
Fair value of common stock granted for services	277,600	1,554,800
Fair value of common stock issued for product license and option	4,250,000	0
Fair value of warrants granted for services	79,800	0
Loss on extinguishment of accounts payable	(22,700)	(135,000)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	34,600	259,600
Accounts payable and accrued expenses, including accrued interest	511,800	(41,800)
Deferred rent	109,200	159,900
Net cash used in operating activities	(10,970,300)	(6,454,700)
Cash flows from investing activities:
Purchases of equipment	0	(1,600)
Construction of tenant improvements	(169,800)	0
Net cash used in investing activities	(169,800)	(1,600)
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including Units	6,608,700	16,721,900
Proceeds from exercise of warrants	605,700	0
Repayment of capital lease obligations	(2,000)	(1,700)
Repayment of notes payable	(165,300)	(153,400)
Net cash provided by financing activities	7,047,100	16,566,800
Net (decrease) increase in cash and cash equivalents	(4,093,000)	10,110,500
Cash and cash equivalents at beginning of period	10,378,300	2,921,300
Cash and cash equivalents at end of period	6,285,300	13,031,800
Supplemental disclosure of noncash activites:
Insurance premiums settled by issuing note payable	160,500	142,400
Accrued dividends on Series B Preferred	848,000	766,600
Deemed dividend from trigger of down round provision feature	0	(199,200)
Settlement of accounts payable by issuance of common stock	$ 40,000	$ 450,000